Today, we take a lot of things for granted. We do not ask ourselves where they have come from, what they are made of or how they have been made.

Similar documents
IMPORTANT NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS OF THE KRKA GROUP FOR 2006

IMPORTANT NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS OF THE KRKA GROUP FOR 2005

Krka Business Performance in 2018

Krka s business performance in 2013

EXPOFORUM EXPERIENCE MOMENTUM

TRIPS OF BULGARIAN RESIDENTS ABROAD AND ARRIVALS OF VISITORS FROM ABROAD TO BULGARIA IN NOVEMBER 2018

TRIPS OF BULGARIAN RESIDENTS ABROAD AND ARRIVALS OF VISITORS FROM ABROAD TO BULGARIA IN FEBRUARY 2018

TRIPS OF BULGARIAN RESIDENTS ABROAD AND ARRIVALS OF VISITORS FROM ABROAD TO BULGARIA IN OCTOBER 2017

TRIPS OF BULGARIAN RESIDENTS ABROAD AND ARRIVALS OF VISITORS FROM ABROAD TO BULGARIA IN NOVEMBER 2017

TRIPS OF BULGARIAN RESIDENTS ABROAD AND ARRIVALS OF VISITORS FROM ABROAD TO BULGARIA IN JANUARY 2018

The economic impact of ATC strikes in Europe Key findings from our updated report for A4E

09-11 May 2017 Palexpo, Geneva, Switzerland

PRESS RELEASE. Krka presented its operating results for the first quarter of 2018

PRESS RELEASE. Krka Publishes January to September 2018 Operating Results. Sales

CCBE LAWYERS STATISTICS 2016

An overview of Tallinn tourism trends

NLB d.d., Ljubljana PRESENTATION

Adequate information for tourism will help us to:

EUROCONTROL. Visit of the Transport Attachés. 10 April Frank Brenner. Director General EUROCONTROL

IMD World Talent Report Factor 1 : Investment and Development

PRESS RELEASE. Krka presented its operating results for the first half of 2017

Common Market Organisation (CMO) Fruit and vegetables sector Evolution of EU prices of some F&V products

LifeWatch, costing and funding. The LifeWatch e-infrastructure financial issues

ELEVENTH AIR NAVIGATION CONFERENCE. Montreal, 22 September to 3 October 2003

Unaudited Interim Report for the Krka Group and Krka, d. d. for the First Quarter of 2018

The exhibition is carried out through international exhibitions and commodity groups, which saves time of exhibitors.

Table I. General questions

The Group. Only passions, great passions, can elevate the soul to great things.

TRIPS OF BULGARIAN RESIDENTS IN ABROAD AND ARRIVALS OF VISITORS FROM ABROAD TO BULGARIA IN FEBRUARY 2011

GODINA XI SARAJEVO, BROJ 2 TOURISM STATISTICS. Tourism in BIH, February 2017

Cumulative Investments by Sector. Cumulative Investment by Country. Industry, Commerce & Agribusiness 18% Transport 30% Natural Resources 2%

Network Management, building on our experience of flow management and network planning.

Indoor Radon: A Public Health Perspective

Institute for Leisure Economics

the Fresh show! INFORMATIVE DOCUMENT FOR EXHIBITORS INTERNATIONAL TRADE SHOW FOR FRUIT & VEGETABLES

International Green Week January, Berlin

INVESTMENT OPPORTUNITIES IN VOJVODINA. VOJVODINA INVESTMENT PROMOTION VIP Branislav Bugarski, VIP CEO

The Nordic Countries in an International Comparison. Helga Kristjánsdóttir 20. apríl 2012

BALKAN SPA SUMMIT. Spa, Wellness, Thalasso, Thermal & Health Tourism Expo & Conference Of The Balkan Countries

NORWAY SWEDEN FINLAND RUSSIA DENMARK NETHERLANDS GERMANY POLAND BELGIUM CZECH REPUBLIC AUSTRIA HUNGARY SWITZERLAND CHINA MEDITERRANEAN SEA

From: OECD Tourism Trends and Policies Access the complete publication at:

SLOVAKIA. Table 1. FDI flows in the host economy, by geographical origin. (Millions of US dollars)

Unaudited Interim Report for the Krka Group and the Krka Company for January March 2014

REVIEW 2017 NOVEMBER 12 18, HANOVER

Dr. Violeta Vinceviciene, DG ENV D.2

Global Travel Trends 2005

FEDERATION SQUARE MELBOURNE, AUSTRALIA CORPORATE PLAN

External Quality of Service Monitoring

% change vs. Dec ALL VISITS (000) 2,410 12% 7,550 5% 31,148 1% Spend ( million) 1,490 15% 4,370-1% 18,710 4%

JAR-21: CERTIFICATION PROCEDURES FOR AIRCRAFT AND RELATED PRODUCTS AND PARTS. Please find attached a copy of JAR-21 Amendment 7 dated February 2007.

Where ideas meet results. 5 th Haemophilia Global Summit Barcelona, September

PRESS RELEASE No. 24 of February 3, 2014 Tourism December and the Year 2013

Greene County Tourism Economic Impact Analysis and Strategic Goals

9 YEARS OF CEI UNIVERSITY NETWORK (CEI UniNet): Academic Cooperation through Mobility

Rules for reimbursement of expenses for delegates attending meetings

TAIEX. Institution Building support for Agriculture and Rural Development by Twinning and TAIEX. Institution Building Unit DG Enlargement

European General Aviation Conference Schonhagen Airport. Martin Robinson CEO AOPA UK Deputy Vice President IAOPA Europe Berlin 15 th May 2006

A spotlight on tourism in CEE. Christopher Hinteregger, 14 th May 2012, Vienna

STRATEGY OF DEVELOPMENT 2020 OF THE CCI SYSTEM IN UKRAINE

Unaudited Interim Report for the Krka Group and Krka, d. d. for the Period from January to September 2018

Please find attached a copy of JAR-66 Amendment 2 dated February 2007.

Prof. Dr. Olga Hadžić Former Rector of the University of Novi Sad Faculty of Sciences, University of Novi Sad, Serbia Dr. Aleksandra Dragin Faculty

London s Air Ambulance: telling the right story

Company Profile.

JAR-147: APPROVED MAINTENANCE TRAINING/EXAMINATIONS. Please find attached a copy of JAR-147 Amendment 3 dated February 2007.

FACTS & FIGURES ISE 2016

CEFS SUGAR STATISTICS 2010

Development and implementation of a marketing strategy for the European ecolabel on textiles and shoes in Denmark

Latest Hotels.com research reveals Chinese travellers want more of everything more time travelling, more locations and more exotic experiences

Krka s business performance in 2015

Structured UNiversity mobility between the Balkans and Europe for the Adriatic-ionian Macroregion

Creating Partnerships for Sustainable Tourism Development. Marjan Hribar M.Sc. Director general Directorate for tourism and internationalisation

International Civil Aviation Organization WORLDWIDE AIR TRANSPORT CONFERENCE (ATCONF) SIXTH MEETING. Montréal, 18 to 22 March 2013

Aerodays 2011 Madrid, 30 March Dr. Mathias Stranznbach The Federal Ministry of Economics and Technology - BMWi

ANNUAL TOURISM REPORT 2013 Sweden

COMMUNICATION FROM THE COMMISSION TO THE COUNCIL

Unaudited Interim Report for the Krka Group and the Krka Company for January September 2013

Life in the FIRST lane Chinese travellers swap old habits for new first time experiences

Over 2017, FPC s domestic passenger traffic grew by 1.4%. MACROECONOMIC ENVIRONMENT. Indicators 2017

ASPHALT IN FIGURES 2015 ASPHALT IN FIGURES

Pacific Resort Hotel Group

RAMSAY HEALTH CARE REPORTS 17.7% RISE IN FULL YEAR CORE EPS AND 16.8% RISE IN CORE NET PROFIT

LETTER FROM THE CHAIRMAN OF THE BOARD

JAR-145: APPROVED MAINTENANCE ORGANISATIONS. Please find attached a copy of Amendment 6 to JAR-145, effective 1 November 2004.

Россия/Russia + Important roads of Europe 2013 FX

BABIA GÓRA DECLARATION ON SUSTAINABLE TOURISM DEVELOPMENT IN MOUNTAIN AREAS

EU-Russia summit Strong recovery of trade in goods between EU27 and Russia in 2011 An EU27 deficit of 91 bn euro with Russia in 2011

GREET VIENNA Global Real Estate & Economy Talks. The meeting point for decision makers of the international and national real estate business

Please find attached a copy of JAR-25 Amendment 20 dated December 2007.

Estonia. Tourism in the economy. Tourism governance and funding

Life cycle Solutions partner for the entire life cycle of industrial assets

Tourist arrivals and overnight stays in collective accommodation 1 July 2017 (p)

irport atchment rea atabase

Government Keynote Address. Delian Dobrev, Minister of Economy, Energy and Tourism

FINAL PRESS CONFERENCE TO FINISH THE PROJECT

Keep your talent. Keep your culture. Keep your say. ACQUISITION: this is where your legacy continues.

Krka presented its operating results for the period January September 2017

Management of a Large The Danube. Mr. Mitja Bricelj ICPDR President Perth,13 October 2010

Transnational Cooperation in Cultural Tourism Development and Promotion: The CHIRON Project legacy and prospects for the experience economy

2008 Avon Russia Investor Meeting

Transcription:

Today, we take a lot of things for granted. We do not ask ourselves where they have come from, what they are made of or how they have been made. That is why it is so important to know who we can trust. Because top quality has a name.

Our knowledge for your health. Our knowledge for your health. Our knowledge for your health. Our knowledge for your health. Our knowledge for your health. 5 Living a healthy life.

Looking ahead In the span of over six decades, Krka has consolidated its position as one of the main generic pharmaceutical companies in the world. Our reputation is based on quality products and business excellence. Every day, Krka s medicines are used to treat of 45 million people who trust our company, around the world. We are embarking on the future with a clear strategy, new products and new markets. We have several reasons to be optimistic, but, most importantly, we have our in-house knowledge and cutting-edge production capacities, we manage the entire process from the development of active ingredients to finished products, and we know how to respond to changes quickly. But even the most cutting-edge technology is only technology when it is not used by creative and enthusiastic people who are loyal to their company. I believe in the power of knowledge, work and cooperation. I trust my colleagues, and believe that we will continue to help people to live a healthy life. Jože Colarič President of the Management Board and CEO 6

WHO WE ARE

Bold beginnings, great achievements We are proud that we have been successfully taking care of people s health all around the world for over 60 years. The story of Krka began in 1954 when Boris Andrijanič established the Krka Pharmaceutical Laboratory in Novo mesto. 9 Living a healthy life.

At first, nine people worked in two small laboratories and in the production and packaging room with a tabletting machine and a machine for mixing medicines. A development institute was established as early as in the first decade of the company s operations; the first patents were registered, and the production and sales of cosmetic products began, and the first export steps were taken. 10

Today, we are one of the leading global manufacturers of generic medicines By making decisive moves, we have developed into an international pharmaceutical business group with more than 12,000 employees. With stable sales growth, investments, several development projects and good results, we have grown into a group that, in addition to the controlling company in Slovenia, also comprises several subsidiaries and representative companies in over 40 countries. 11 Living a healthy life.

KRKA GROUP OVER 45 COMPANIES AND REPRESENTATIVE OFFICES OVER 70 MARKETS OVER 12,000 EMPLOYEES, HALF OF WHOM WORK OUTSIDE SLOVENIA 12

13 Living a healthy life.

In the company of the best We sell over 1 billion worth of products and services per year, which ranks us among the leading generic pharmaceutical companies. Our products are available in over 70 countries around the world. 14

Living a healthy life With development, production and sales of pharmaceuticals we are paving the way that leads to better health. 15 Living a healthy life.

MISSION LIVING A HEALTHY LIFE. VISION WE ARE CONTINUALLY CONSOLIDATING OUR POSITION AS ONE OF THE LEADING GENERIC PHARMACEUTICAL COMPANIES IN THE WORLD. OUR VALUES SPEED AND FLEXIBILITY PARTNERSHIP AND TRUST CREATIVITY AND EFFICIENCY 16

The Krka Group s Strategy is the basis of our development Our development strategy is drawn up for a five-year period. To adapt to constantly changing business circumstances, it is updated every two years. 17 Living a healthy life.

KEY STRATEGIC OBJECTIVES UP TO 2022 To attain at least 5% average annual sales growth in terms of quantities/value. To ensure sufficient quantities of manufactured products through an efficient and optimised development-and-production chain in accordance with the required quality standards in a timely manner, which will be in line with the target sales growth and market needs. To focus on maximising the long-term profitability of products sold from development and production to sales of finished products, including all other functions within the Krka Group. To ensure growth by acquisitions and long-term partnerships (including joint ventures) in addition to organic growth, when interesting and available target companies become available. The primary goals are to secure new products and/or markets. To maintain the largest possible share of new products in total sales and the share of vertically integrated products, in addition to the existing range of products, also referred to as the golden standard. To launch a selected product portfolio in selected key target markets as the first generic pharmaceutical company. To strengthen the competitive advantage of our product portfolio. To improve the cost-effective use of all assets. To increase the degree of innovation across all business functions. To remain independent. 18

WE PRODUCE GENERIC MEDICINES WITH ADDED VALUE

21 Living a healthy life.

Generic prescription medicines marketed under Krka s own brands are the most important items in our range of products. 22

Krka s medicines are a product of knowledge and innovation, and are equivalent to the originators. This means that they contain the same active substances, and that they have the same effect on the human body. They often are even more advanced and better quality, as they are based on the latest scientific and technological findings. Accurate tablet sample preparation for microscopic and micro-elemental analysis providing insight into the composition and a detailed analysis of individual components. 23 Living a healthy life.

GENERIC MEDICINES SAME ACTIVE INGREDIENTS SAME QUALITY, SAFETY AND EFFICACY MORE ADVANCED MORE AFFORDABLE 24

We continuously invest in research and development, which ranks us among the leading companies in Europe. For the successful development of a medicinal product, we need knowledge from various fields. Experts from more than 30 different branches of science and engineering work together in pharmaceutical development based on our own knowledge and innovation. Our experts synthesise active ingredients and develop technological procedures for manufacturing various finished products. Krka holds patents for innovative methods and procedures. More than 350 of Krka s innovations are protected by patents in many European, American and Asian countries. 25 Living a healthy life.

INNOVATIVE APPROACHES TO THE DEVELOPMENT AND PRODUCTION OF GENERIC MEDICINES OVER 600 EXPERTS DEVELOP NEW PRODUCTS 10% OF SALES REVENUES ARE ALLOCATED TO RESEARCH AND DEVELOPMENT WE HAVE PATENTED OVER 350 INNOVATIONS 26

THE PATH TO A HIGH-QUALITY, SAFE AND EFFECTIVE MEDICINAL PRODUCT

The product s life cycle is in our hands When it comes to health, only the best is good enough. We at Krka carefully plan the development of medicines. The vertically integrated business model is applied to control the entire production path of our products. We develop and manufacture the entire medicinal product, from the active ingredient to the finished product. With prompt marketing authorisation and distribution to markets, we ensure that the medicine reaches the patient. An increase in contractual cooperation for the manufacture of finished products outside the Krka Group will promote further growth. 29 Living a healthy life.

VERTICALLY INTEGRATED BUSINESS MODEL 70% of our products are vertically integrated. WE DEVELOP AND PRODUCE ACTIVE INGREDIENTS WE DEVELOP AND PRODUCE FINAL PRODUCTS WE SELL AND MARKET QUALITY, SAFE AND EFFECTIVE MEDICINES 30

We ensure growth with investments We know that the future brings new challenges and requires us to act in a smart and decisive manner. Our strategic objective to develop our own generic medicines is realised by investing in production, and development and in research capacities. Notol 2 is the largest investment in Krka s history. It is the most technically and technologically advanced plant, and as such it is a reflection of everything that Krka is today. 31 Living a healthy life.

TOTAL CAPACITY: 17 BILLION TABLETS AND CAPSULES OUR PRODUCTS AND ACTIVE INGREDIENTS ARE PRODUCED IN STATE- OF THE-ART AND TECHNOLOGICALLY ADVANCED PRODUCTION PL ANTS ACROSS EUROPE. SLOVENIA GERMANY THE RUSSIAN FEDER ATION POL AND CROATIA 32

We develop advanced and innovative dosage forms We manage technology for the production of solid, semi-solid and liquid pharmaceutical products, such as tablets, capsules, injections, syrups, creams and sprays. We synthesise active ingredients according to our own innovative procedures, and use the most sophisticated technology in the research and production of innovative dosage forms. 33 Living a healthy life.

TABLETS WITH PROLONGED RELEASE ENABLE A LOWER NUMBER OF DOSES. KRKA S DOUBLE AND TRIPLE COMBINATIONS OF ACTIVE INGREDIENTS PROVIDE FOR IMPROVED PATIENT COMPLIANCE AND ADVERSE EVENT CONTROL. 34

Precise micro-elemental analysis of individual components of a medicine that also determines the physical and microbiological properties: particle size, form and position of the active substance and other ingredients in the tablet. UP TO 25,000 ANALYSES DURING THE PRODUCT DEVELOPMENT STAGE CLINICAL STUDIES INVOLVING ALMOST 350,000 PATIENTS IN 27 COUNTRIES 35 Living a healthy life.

Quality is a prerequisite for good results Our products are high quality, safe and effective. With many laboratory tests and analyses, we ensure top quality in all stages of development and production. The safety and efficacy of Krka s medicines are confirmed with extensive clinical testing. Experts from more than 30 different branches of science and engineering work together in pharmaceutical development, which is based on our own knowledge and innovation. 36

We are committed to high quality standards The entire manufacturing, control and distribution process meets good practice guidelines and the highest requirements of current legislation on the pharmaceutical industry. This has also been demonstrated in practice, as nearly 350,000 patients in 27 countries have participated in clinical studies of our medicinal products. 37 Living a healthy life.

WE FOLLOW THE HIGHEST INTERNATIONAL AND PRODUCTION STANDARDS GMP Good Manufacturing Practice GCP Good Clinical Practice GQCLP Good Quality Control Laboratory Practice GDP Good Distribution Practice GPVP Good Pharmacovigilance Practice 38

OUR ACHIEVEMENTS

Krka s medicines are used to treat over 45 million patients every day At Krka, we manufacture prescription pharmaceuticals, non-prescription and animal health products. The Company s range is supplemented by the health resort and tourist services of Terme Krka. Our presence in foreign markets and our market shares indicate that we are on the right track. We are continuously expanding our marketing and sales network, lately particularly to western European markets. 41 Living a healthy life.

Over 80% of sales are generated by prescription pharmaceuticals More than 90% of our products are sold in foreign markets Prescription pharmaceuticals Non-prescription products Animal health products Central Europe East Europe Overseas Markets Other Health resort and tourist services West Europe Slovenia South-East Europe 42

The most important products of the Krka Group are prescription medicines Our main therapeutic groups include pharmaceuticals for cardiovascular diseases, followed by pharmaceuticals for diseases of the central nervous system, pharmaceuticals for alimentary and metabolic diseases, and medicines for the systemic treatment of infections. Medicines for the treatment of diseases of the alimentary tract and metabolism Medicines for the treatment of cardiovascular diseases Other Medicines for the treatment of diseases of the urinary tract We rank among the leading manufacturers of medicines for lowering high blood pressure and cholesterol, and gastric ulcer and reflux. We are very successful in the field of medicines for treating depression, psychoses, Alzheimer s disease, Parkinson s disease, and pain relief. 43 Living a healthy life. Medicines for the treatment of diseases of the blood and blood-forming organs Medicines for the systemic treatment of infections Medicines for the treatment of diseases of the central nervous system

We generate 10% of sales with non-prescription products Cough remedies Vitamins and minerals Other Products with an effect on nasal mucosa Products with an effect on alimentary tract and metabolism Among non-prescription products the most important are products acting on the oral cavity and pharynx (Septabene and Septolete ) and nasal mucosa (Septanazal ), cough and cold remedies (Herbion syrups), analgesic Nalgesin (naproxen), products for improving memory and concentration Bilobil (gingko biloba), and vitamin and mineral products Pikovit. Products with an effect on the oral cavity and pharynx Analgesics Products enhancing cerebral and peripheral circulation 44

We generate over 5% of sales with animal health products Antiparasitics for companion animals We produce animal health products, especially anti-microbial medicines and antiparasitics. For farm animals, the most important products are Enroxil (enrofloxacin) and Floron (florfenicol), and Fypryst (fipronil) and Milprazon for companion animals. (milbemycin oxime/praziquantel) and Ataxxa (imidaclopride/permethrin). 45 Living a healthy life. Antimicrobial pharmaceuticals for food-producing animals Other products for farm animals Antiparasitic Other products for products for companion animals companion animals Antimicrobial pharmaceuticals for companion animals

We are entering the future with new products New products launched during the last five years account for more than one third of total sales. Krka has more than 170 new products in the pipeline. 46

OUR CONTRIBUTION TO YOUR ACHIEVEMENT

49 Living a healthy life.

Social responsibility is one of Krka s main principles We don t only measure success in terms of numbers. We consider ourselves successful when our success has a positive effect on the natural and social environment. It is a challenging mission to which we are fully committed. 50

Our strategy is based on the principles of sustainable development Environmental protection is an important aspect of Krka s business strategy. By obtaining the environmental certificate ISO 14001, we made a commitment to taking a systematic approach to environmental protection, which we will continually upgrade. We have a clear definition of our responsibility to the natural environment in our environmental policy. We continue to apply available top-notch technologies and follow the most contemporary guidelines, which are aimed at the rational use of natural resources and energy, as well as reducing all emissions into the environment. Compliance with environmental legislation and environmental protection permits is checked with regular monitoring of emissions into air and water, noise monitoring and waste assessment. Krka has twice been named an energy - efficient company. In 2010, we installed the first photovoltaic power station and bought an electric vehicle. There is also a charging station for electric vehicles located in front of Krka s headquarters. 51 Living a healthy life.

OUR KNOWLEDGE FOR A HEALTHY ENVIRONMENT 15% OF ELECTRIC ENERGY IS OBTAINED FROM OUR OWN ALTERNATIVE ENERGY SOURCES 86% OF NON-HAZARDOUS WASTE IS PROCESSED AND RECYCLED WATER CONSUMPTION IN THE LAST FIVE YEARS HAS BEEN REDUCED BY 45% DESPITE EXPANDING PRODUCTION 52

We take care that our employees lead a healthy and high-quality life We are aware that Krka s business excellence is measured according to work efficiency and the know-how of employees. We aspire to recruit capable personnel, and to keep employees motivated and committed, while building a culture of an international company. 53 Living a healthy life. A dynamic international environment offers many challenges and opportunities for growth and development. Thousands of Krka employees speak many languages, but live a common story.

54

Boosting our mission, we have been supporting Krka employees attendance at sports and cultural events ever since the following two societies were founded. Krka s Culture and Arts Society has been bringing together art enthusiasts at events which it has been organising since 1971. Trim klub Krka encourages employees to take up a healthy and active lifestyle. 55 Living a healthy life. Our mission Living a healthy life, has been included in the Caring for your health Together We Scale the Heights campaign. Together with the Slovenian Mountaineering and Climbing Association, we signposted and did maintenance work on 15 popular hiking routes around Slovenia.

56

57 Living a healthy life.

Knowledge is a Krka value The knowledge, experience and motivation of every employee are of the utmost significance for the company s growth. More than half of all employees in the Krka Group have completed at least university level education. We work with young people and help them gain experience even before they enter the job market. We offer scholarships for scientific and engineering study programmes, especially to pharmacists and chemists. Krka Prizes have been encouraging young people to engage creativity and excellence in research for over 40 years. Over 2,300 people have received Krka Awards. 58

We believe in the power of knowledge, work and cooperation In accordance with our basic mission, we allocate most of our sponsorships and donations to projects related to health and the quality of life. We give priority to long-term health improvement and humanitarian projects, and invest in sports, education, science and culture. WE SUPPORT YOUNG PEOPLE S ACTIVITIES AND ENCOURAGE THEM TO DEVELOP THEIR TALENTS. 59 Living a healthy life. WITH SPONSORHIPS AND DONATIONS WE CONTRIBUTE TO THE DEVELOPMENT OF OVER 800 ORGANISATIONS EVERY YEAR.

Krka s week of humanity and volunteering has been organised in April every year since 2012 under the slogan Charity is also a part of us. Charity is a part of us Our contribution to social progress also includes the voluntary work of Krka employees. There are over 1300 blood donors in the company. Several employees are members of various non-profit associations and organisations. The spirit of volunteering among Krka employees is also reflected in the charity event Krka s Week of Charity and Volunteering. 60

We take care of responsible and ethical communications Our focus is on our employees, the professional public, business partners, buyers and end consumers, and investors, as well as other representatives of the public important for Krka. We maintain an open relationship with the local and wider community. We organise meetings with the residents of the local community, and we invite those who are sponsored by Krka, to organise open-door days and welcome visits from various groups. 61 Living a healthy life.

YOU CAN FOLLOW INFORMATION ON KRKA AND OUR PRODUCTS IN VARIOUS MEDIA Web portal of the Ljubljana Stock Exchange SEOnet Utrip prihodnosti magazine Corporate website www.krka.biz LinkedIn Product web pages 62

TERME KRKA

For a more pleasant, more creative and healthier life As part of the Krka Group Terme Krka has the leading market share in the health resort industry. It comprises health resorts in Dolenjske Toplice and Šmarješke Toplice, the Talaso Strunjan coastal centre, and Hoteli Otočec hotels, with a top hotel in one of the most beautiful Slovenian castles, a golf course and a business hotel, Hotel Krka, in Novo mesto. 65 Living a healthy life.

66

High quality and a personal approach The basic activity of Terme Krka is medical rehabilitation after illnesses of the musculoskeletal system, and cardiovascular and respiratory illnesses. We were the first in Slovenia to offer our guests medical wellness programmes to help with weight issues and inappropriate reaction to stressful situations. We are known for effective detoxification programmes and healthy weight loss programmes, which ensure excellent results through the cooperation of personal trainers, nutritionists and doctors. We offer wellness programmes, so that our guests can enjoy active relaxation. We spoil them in modern thermal oases with a top relaxation offer. The Balnea and Salia wellness centres offer many different facial and body treatments, massages and baths. Guests can also indulge in gastronomic and sports activities, especially tennis and golf. We also engage in congress tourism. HEALTH 67 Living a healthy life.

WELLNESS ACTIVE RELAXATION BUSINESS EVENTS GOLF CULINARY DELIGHTS 68

Krka in international markets Krka - COMPANIES Addresses and telephone numbers at www.krka.biz/en/about-krka/krka-business-network/companies/ 69 Living a healthy life.

Krka Group Organisation Chart Poland KRKA - POLSKA, Sp. z o.o. Russian Federation OOO KRKA-RUS Czech Republic KRKA ČR, s. r. o. Hungary KRKA Magyarország Kft. 1 CENTRAL EUROPE EAST EUROPE Russian Federation KRKA FARMA LLC Ukraine KRKA UKRAINE LLC Slovakia KRKA Slovensko, s.r.o. Kazakhstan LLT KRKA Kazakhstan Lithuania UAB KRKA Lietuva Latvia SIA KRKA Latvija KRKA, d. d., Novo mesto Germany TAD Pharma GmbH TERME KRKA, d. o. o., Novo mesto FARMA GRS, d. o. o., Novo mesto Sweden Krka Sverige AB Austria KRKA Pharma GmbH, Wien SLOVENIA Ireland KRKA PHARMA DUBLIN LIMITED Croatia KRKA-FARMA d.o.o. Portugal KRKA Farmacêutica, Unipessoal Lda. Romania KRKA ROMANIA S.R.L. Serbia KRKA-FARMA DOO BEOGRAD SOUTH-EAST EUROPE WEST EUROPE Spain KRKA FARMACÉUTICA, S.L. Italy KRKA FARMACEUTICI MILANO S.R.L. Macedonia KRKA-FARMA DOOEL Skopje Bosnia and Herzegovina KRKA FARMA d. o. o., Sarajevo Bulgaria KRKA Bulgaria EOOD USA KRKA USA LLC OVERSEAS MARKETS China Ningbo Krka Menovo Pharmaceutical Company Ltd France KRKA France Eurl à capital variable Belgium KRKA Belgium, SA Great Britain KRKA UK Ltd Finland KRKA Finland Oy Production and distribution companies Joint venture for development, production and distribution Health resort and tourist services company Other subsidiaries outside Slovenia The EU project: Research and development company 70

Only the best is good enough for your health.

Company name and address: KRKA, d. d., Novo mesto Šmarješka cesta 6 8501 Novo mesto Slovenia Contact us: +386 7 331 21 11 info@krka.biz www.krka.biz www.linkedin.com/company/krka Issued and published by Krka, d. d., Novo mesto Šmarješka cesta 6 8501 Novo mesto Slovenia Telephone +386 (0)7 331 21 11 E-mail info@krka.biz www.krka.biz Design and photography Krka, d. d., Novo mesto Printed by Gorenjski tisk storitve, d. o. o., Kranj Novo mesto, May 2018 Gorenjski tisk, 05/2018, Slovenia, 387-2018, RB/KS.